Scarica l'app Stockscreener
0.758
30.98%
0.1793
Dopo l'orario di chiusura:
1.26
0.502
+66.23%
Profusa Inc Borsa (PFSA) Ultime notizie
PFSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
NVACW SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Profusa Delays Annual Report Amid Wider Losses - TipRanks
Profusa (NVACW) delays 2025 Form 10-K; $31.9M loss after merger - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA Should I Buy - Intellectia AI
Profusa Incenters amendment to promissory note with Northview Sponsor I LLC on March 20, 2026SEC filing - MarketScreener
Profusa Extends Promissory Note Maturity, Enhancing Liquidity - TipRanks
Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Profusa (PFSA) Stock Forecast and Price Target 2026 - MarketBeat
NVACW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process By Investing.com - Investing.com Canada
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), biosensor technology company Profusa Inc has officially decided to terminate its Bitcoin treasury reserve strategy. - Bitget
Profusa terminates Bitcoin Treasury Reserve Strategy and to liquidate Bitcoin holdings - marketscreener.com
Profusa to liquidate Bitcoin holdings and faces Nasdaq delisting process - Investing.com
Profusa to End Account Control Agreement With Ascent Partners as It Exits Bitcoin Strategy - TradingView
Profusa (NASDAQ: NVACW) warned on delisting as it ends Bitcoin reserve plan - Stock Titan
Profusa (PFSA) & Its Peers Financial Contrast - Defense World
PFSA Earnings History & Surprises | EPS & Revenue Results | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Mayo Clinic to Advance Clinical Applications of Oxygen Monitoring Technologies - Medical Product Outsourcing
[POS AM] Profusa, Inc. SEC Filing - Stock Titan
Head-To-Head Comparison: Profusa (PFSA) versus Its Competitors - Defense World
PFSA Technical Analysis & Stock Price Forecast - Intellectia AI
Profusa cancels $15M public offering, plans smaller fundraise By Investing.com - Investing.com Canada
Profusa cancels $15M public offering, plans smaller fundraise - Investing.com South Africa
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering - GlobeNewswire
Biosensor technology company Profusa Inc announced that revenue from its Lumee oxygen monitoring product in the European market is expected to receive substantial support starting from the second quarter of 2026. - Bitget
Profusa’s Market Moves as Revenue Reports Spark Uncertainty - StocksToTrade
Profusa Inc. Stock Declines Amid Financial Struggles and Market Uncertainty - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Profusa (PFSA) vs. Its Competitors Head-To-Head Review - Defense World
Analyzing Profusa (PFSA) and The Competition - Defense World
CapsoVision (NASDAQ:CV) and Profusa (NASDAQ:PFSA) Head-To-Head Review - Defense World
Contrasting Profusa (PFSA) & Its Rivals - Defense World
Contrasting Profusa (PFSA) & Its Peers - Defense World
Profusa raises 2026 revenue forecast on European purchase orders By Investing.com - Investing.com South Africa
Profusa raises 2026 revenue forecast on European purchase orders - Investing.com Nigeria
Profusa Raises 2026 Revenue Guidance to $3 Million Amid Strong Demand - Intellectia AI
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance - The Manila Times
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Profusa (PFSA) and Its Rivals Head to Head Analysis - Defense World
Contrasting Profusa (PFSA) & Its Competitors - Defense World
Profusa (PFSA) & Its Peers Head-To-Head Review - Defense World
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):